Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Class IIa histone deacetylases: regulating the regulators
Maud Martin, R. Kettmann, Samuel Dequiedt
Oncogene (2007) Vol. 26, Iss. 37, pp. 5450-5467
Closed Access | Times Cited: 234

Showing 1-25 of 234 citing articles:

The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Xiang-Jiao Yang, Edward Seto
Nature Reviews Molecular Cell Biology (2008) Vol. 9, Iss. 3, pp. 206-218
Open Access | Times Cited: 1175
Biological and Chemical Approaches to Diseases of Proteostasis Deficiency
Evan T. Powers, Richard I. Morimoto, Andrew Dillin, et al.
Annual Review of Biochemistry (2009) Vol. 78, Iss. 1, pp. 959-991
Closed Access | Times Cited: 1108
HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention
X-J Yang, Edward Seto
Oncogene (2007) Vol. 26, Iss. 37, pp. 5310-5318
Open Access | Times Cited: 941
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Aleksey Kazantsev, Leslie M. Thompson
Nature Reviews Drug Discovery (2008) Vol. 7, Iss. 10, pp. 854-868
Closed Access | Times Cited: 697
Histone deacetylases as regulators of inflammation and immunity
Melanie R. Shakespear, Maria A. Halili, Katharine M. Irvine, et al.
Trends in Immunology (2011) Vol. 32, Iss. 7, pp. 335-343
Closed Access | Times Cited: 499
Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors
Geneviève P. Delcuve, Dilshad H. Khan, James Davie
Clinical Epigenetics (2012) Vol. 4, Iss. 1
Open Access | Times Cited: 446
Structural and Functional Analysis of the Human HDAC4 Catalytic Domain Reveals a Regulatory Structural Zinc-binding Domain
Matthew J. Bottomley, Paola Lo Surdo, Paolo Di Giovine, et al.
Journal of Biological Chemistry (2008) Vol. 283, Iss. 39, pp. 26694-26704
Open Access | Times Cited: 294
Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
Paul V. Licciardi, Ververis, Hiong, et al.
Biologics (2013), pp. 47-47
Open Access | Times Cited: 276
The Redox Basis of Epigenetic Modifications: From Mechanisms to Functional Consequences
Anthony R. Cyr, Frederick E. Domann
Antioxidants and Redox Signaling (2010) Vol. 15, Iss. 2, pp. 551-589
Open Access | Times Cited: 271
HDAC4: Mechanism of Regulation and Biological Functions
Zhengke Wang, Gangjian Qin, Ting C. Zhao
Epigenomics (2014) Vol. 6, Iss. 1, pp. 139-150
Open Access | Times Cited: 213
Histone Deacetylase Inhibitors Modify Pancreatic Cell Fate Determination and Amplify Endocrine Progenitors
Cécile Haumaître, Olivia Lenoir, Raphaël Scharfmann
Molecular and Cellular Biology (2008) Vol. 28, Iss. 20, pp. 6373-6383
Open Access | Times Cited: 178
Histone Deacetylase 5 Acquires Calcium/Calmodulin-Dependent Kinase II Responsiveness by Oligomerization with Histone Deacetylase 4
Johannes Backs, Thea Backs, Svetlana Bezprozvannaya, et al.
Molecular and Cellular Biology (2008) Vol. 28, Iss. 10, pp. 3437-3445
Open Access | Times Cited: 175
Class IIa HDACs – new insights into their functions in physiology and pathology
Maribel Parra
FEBS Journal (2014) Vol. 282, Iss. 9, pp. 1736-1744
Open Access | Times Cited: 163
Histone Deacetylase Inhibitors In The Treatment Of Cancer: Overview And Perspectives
Giuseppe Giannini, Walter Cabri, Caterina Fattorusso, et al.
Future Medicinal Chemistry (2012) Vol. 4, Iss. 11, pp. 1439-1460
Closed Access | Times Cited: 163
HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
Michał Mielcarek, Christian Landles, Andreas Weiss, et al.
PLoS Biology (2013) Vol. 11, Iss. 11, pp. e1001717-e1001717
Open Access | Times Cited: 161
Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
Seung Joon Lee, Candice Krauthauser, Victoria Maduskuie, et al.
BMC Cancer (2011) Vol. 11, Iss. 1
Open Access | Times Cited: 157
HDAC5 Controls MEF2C-Driven Sclerostin Expression in Osteocytes
Marc N. Wein, Jordan Spatz, Shigeki Nishimori, et al.
Journal of Bone and Mineral Research (2014) Vol. 30, Iss. 3, pp. 400-411
Open Access | Times Cited: 148
Regulatory signal transduction pathways for class IIa histone deacetylases
Maribel Parra, Eric Verdin
Current Opinion in Pharmacology (2010) Vol. 10, Iss. 4, pp. 454-460
Closed Access | Times Cited: 141
Specific Control of Pancreatic Endocrine β- and δ-Cell Mass by Class IIa Histone Deacetylases HDAC4, HDAC5, and HDAC9
Olivia Lenoir, Kathleen Flosseau, Feng Xia, et al.
Diabetes (2011) Vol. 60, Iss. 11, pp. 2861-2871
Open Access | Times Cited: 137
Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology
Ya Fu, Charles S. Rubin
EMBO Reports (2011) Vol. 12, Iss. 8, pp. 785-796
Open Access | Times Cited: 129
The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
Chiara Zagni, Giuseppe Floresta, Giulia Monciino, et al.
Medicinal Research Reviews (2017) Vol. 37, Iss. 6, pp. 1373-1428
Closed Access | Times Cited: 117
Regulation of Class IIa HDAC Activities: It is Not Only Matter of Subcellular Localization
Eros Di Giorgio, Claudio Brancolini
Epigenomics (2016) Vol. 8, Iss. 2, pp. 251-269
Open Access | Times Cited: 116
Six Novel Susceptibility Loci for Early-Onset Androgenetic Alopecia and Their Unexpected Association with Common Diseases
Rui Li, Felix F. Brockschmidt, Amy K. Kiefer, et al.
PLoS Genetics (2012) Vol. 8, Iss. 5, pp. e1002746-e1002746
Open Access | Times Cited: 114
Targeting Histone Deacetylases in Diseases: Where Are We?
Rosaria Benedetti, Mariarosaria Conte, Lucia Altucci
Antioxidants and Redox Signaling (2014) Vol. 23, Iss. 1, pp. 99-126
Open Access | Times Cited: 112
Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
Flávia Alves Verza, Umashankar Das, Ana Lúcia Fachin, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1664-1664
Open Access | Times Cited: 105
Page 1 - Next Page

Scroll to top